Phathom Pharmaceuticals Announces Executive & Director Changes
Ticker: PHAT · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: PHAT
TL;DR
Phathom Pharma (PHAT) board/exec shakeup effective 3/31. New officers elected, comp plans updated.
AI Summary
Phathom Pharmaceuticals, Inc. filed an 8-K on April 1, 2025, reporting changes effective March 31, 2025. The filing indicates a departure of directors or certain officers, the election of new directors, and the appointment of certain officers, along with updates to compensatory arrangements for these officers.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, operational focus, or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- March 31, 2025 (date) — Effective date of reported changes
- April 1, 2025 (date) — Filing date of the 8-K
FAQ
What specific roles have been affected by the departure of directors or officers?
The filing indicates a departure of directors or certain officers, but does not specify the exact roles or individuals in this summary section.
Who were the newly elected directors?
The filing states that directors have been elected, but the names of the newly elected directors are not provided in the initial summary information.
Were there any changes to executive officer positions?
Yes, the filing reports the appointment of certain officers, indicating changes in executive positions.
What is the nature of the updates to compensatory arrangements?
The filing mentions updates to compensatory arrangements for certain officers, but the specific details of these arrangements are not elaborated upon in the provided text.
What is the effective date of these reported changes?
The reported changes, including departures, elections, and appointments, are effective as of March 31, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Phathom Pharmaceuticals, Inc. (PHAT).